Objectives We present here a 60-year-old man with recurrent/metastatic intestinal GIST expressing KIT exon 9/17 mutation benefited from systemic therapy combined with surgery and tyrosine kinase inhib
Objective Gastrointestinal stromal tumors(GISTs)are the most common mesenchymal neoplasms of the digestive tract,surgery is the primary method of treating them.In 1998,Hirota et al reported that GISTs